Cannabis Law Report

SEPTEMBER 16, 2020

The Regulatory Affairs Professionals Society reports… The framework for regulating cannabis as a pharmaceutical product varies widely across the world, though increased clinical research … Read More. The post Article: Medical cannabis regulation is a global patchwork first appeared on Cannabis Law Report.

Pharmaceutical 59

Pharmaceutical Cannabis Law 59

FloridaMarijuana.net

OCTOBER 11, 2018

Trytek and Fiedurek , in their article titled “ Terpenes: Substances Useful in Human Healthcare ,” established that “Terpenes are naturally occurring substances produced by a wide variety of plants and animals. Science is proving that nature can provide the medications that humans need to improve their health. Paduch, Kandefer-Szersze?,

Terpenes 172

Terpenes Strains Medicine Oil 172

SpeedWeed

SEPTEMBER 3, 2021

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 View original article. The post Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025 – Cannabis Business Executive – Cannabis and Marijuana industry news.

Pharmaceutical 55

Pharmaceutical Business Cannabis Marijuana 55

Project CBD

JULY 28, 2023

Scialdone, a recognized expert in the field of organic chemistry who specializes in natural product chemistry, is an inventor of 37 issued US patents and the author of 17 peer-reviewed articles in science publications. From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development.

THC 217

THC Cannabinoids Hemp Research and Development 217

FloridaMarijuana.net

AUGUST 15, 2018

A 2015 article published in The Journal of American Medicine found that that “use of marijuana for chronic pain and neuropathic pain is supported by high-quality evidence. The following excerpt is from an article published by Dr. Mazanet for The Foundation for Peripheral Neuropathy. Antispasmodic. Anticonvulsant/Seizures.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

CannaMD

SEPTEMBER 15, 2022

The legalization of marijuana has been linked to serious financial losses in the pharmaceutical industry, according to one new study. A peer-reviewed article published last month in PLOS ONE confirmed many anecdotal reports involving the growing number of people turning to cannabis as an alternative to traditional medications.

Legalization 105

Legalization Pharmaceutical Marijuana Cannabis 105

Cannabis Law Report

SEPTEMBER 2, 2022

The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. By expanding access and, thus use, legalization could permit cannabis to compete with conventional pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Legalization Marijuana Data 52

SpeedWeed

AUGUST 16, 2021

Healthcare & Pharmaceuticals U.S. View original article. The post Healthcare & Pharmaceuticals U.S. cannabis firm PharmaCann plans IPO as New York weed legalization lifts demand -sources – Cannabis Business Executive – Cannabis and Marijuana industry news.

Pharmaceutical 52

Pharmaceutical Business Legalization Cannabis 52

Project CBD

MARCH 8, 2019

Immediately in response, the FDA announced that CBD is considered a “drug” and is thus subject to pharmaceutical regulations. His forthcoming articles for projectcbd.org will contain practical information on using cannabis to treat medical conditions in pets. And as the saying goes, “As goes California, so goes the nation.”.

Pets 218

Pets Legalization Hemp Extraction 218

FloridaMarijuana.net

OCTOBER 5, 2018

This article in PPAR Research , an indexed science citation journal, states that “terpenoids constitute one of the largest families of natural products accounting for more than 40,000 individual compounds of both primary and secondary metabolisms. Phytol constituents have a mild, light floral, tea scent.

Terpenes 181

Terpenes Strains Oil Medicine 181

CannaMD

FEBRUARY 19, 2020

Medical Marijuana: More Effective Than Pharmaceuticals? To date, there is no pharmaceutical product targeted specifically for the treatment of PTSD. In fact, PTSD treatments based on pharmaceutical antidepressants have been shown to provide just a 60% overall response rate, with only 20 to 30% of patients achieving full remission.

CBD 111

CBD Pharmaceutical Research and Development Conditions 111

Cannabis Law Report

APRIL 17, 2022

Juru points to the example of Italy , where the army is enmeshed in the business of medical cannabis: running pharmaceutical dispensaries; greenhouses; producing the so-called ´orphan drugs, ´ which are expensive medications that cure rare diseases and are not produced in the corporate economy.

Cultivation 98

Cultivation Cannabis Food Pharmaceutical 98

Cannabis Law Report

OCTOBER 5, 2021

“M oney has begun flowing into companies intending to monetize psychedelic therapy as new research has increasingly shown that blowing one’s mind can alter it for the better,” reads an article in The Los Angeles Times titled “Money is pouring into psychedelics. Meet the mystical hedge fund investor bankrolling the boom.”.

Therapy 52

Therapy Pharmaceutical Collective Treatment 52

Cannabis Law Report

AUGUST 1, 2021

In May this year the Greek Parliament passed the draft production, extraction and distribution of final products of pharmaceutical cannabis of the species Cannabis Sativa containing over 0.2% Read the full article at [link]. Tetrahydrocannabinol (THC). Greek Bureaucracy To Blame.

Sativa 105

Sativa Pharmaceutical Extraction Cultivation 105

FloridaMarijuana.net

JUNE 22, 2018

A 2016 study indicated that cannabidiol (CBD), immediately “eases anti-social and reduce anxiety-like behavior in minutes;” these findings suggest that medical marijuana is a better option over common antidepressant pharmaceuticals, which may take up to six weeks to become effective. L: No, but I get extremely frustrated in the actual moment.

Hybrid 189

Hybrid Marijuana Sativa Nerve Pain 189

FloridaMarijuana.net

AUGUST 15, 2018

Evidence-based Complementary and Alternative Medicine published an article titled “Post-Traumatic Stress Disorder: Evidence-Based Research for the Third Millennium” which describes how profound the symptoms of PTSD can be: “Traumatic events are profoundly stressful.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Cannabis Law Report

JULY 7, 2021

Drilling down into the cannabis trademark landscape in 2018 uncovered a heavy focus on goods in Classes 34 (smokers’ articles) and 5 (medicines/pharmaceuticals), as well as Nice classes relating to food and drink products. Smokers’ articles. Smokers’ articles. Dutch Passion Holding BV. Source: CompuMark.

Oil 71

Oil Agriculture Cannabis Food 71

Cannabis Law Report

SEPTEMBER 29, 2021

Idrasil was not an approved pharmaceutical by the insurance companies. The SEC also accuses Steele Smith of making misrepresentations about how investors would make money on their investments, telling them that they would be cashed out once C3 was acquired by a large pharmaceutical company. Read full article at .

Pharmaceutical 98

Pharmaceutical Cannabis Business Law 98

Cannabis Law Report

FEBRUARY 28, 2022

In the pharmaceutical context, patents protect the owner’s investment and the expensive process of drug development and approval. Read full article at. [link]. Obtaining a patent provides an inventor with exclusive rights to the patented process, invention or design for a limited period of time (20 years in the UK).

Therapy 52

Therapy Pharmaceutical Extraction Access 52

Cannabis Law Report

MARCH 1, 2022

High Times write… Alain Menghé à Menghé, the CEO of Lio Pharmaceuticals, a German distributor who is building a manufacturing hub based in Solingen, just outside Dusseldorf, is a bit more pessimistic. Read full article. He expects the outbreak of hostilities to affect the entire industry, even if not directly.

Pharmaceutical 52

Pharmaceutical Medicine Cannabis Compliance 52

Cannabis Law Report

SEPTEMBER 22, 2021

Under the terms of the agreement OCT will use reasonable efforts to develop and commercialise: (i) at least one CBD derivative; (ii) at least one CBG derivative; and (iii) at least one THC derivative, as pharmaceutical drug products. OCT is also responsible for the manufacture and supply of the compounds for development and commercialisation.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Cannabis Law Report

SEPTEMBER 4, 2019

Just look at the pharmaceutical industry and the opioid crisis or Bernie Madoff’s Ponzi scheme or Enron’s accounting fraud. Fresh Toast write… Every industry has its fair share of scandals. All are terrible and the size of those schemes may make the cannabis industry scandals look like small potatoes.

Pharmaceutical 59

Pharmaceutical Events Cannabis Law 59

SpeedWeed

AUGUST 12, 2021

Cannabis Facility Construction Expands into Virginia with Design-Build Project for Dharma Pharmaceuticals – Cannabis Business Executive – Cannabis and Marijuana industry news. View original article. skip to Main Content.

Pharmaceutical 40

Pharmaceutical Business Cannabis Marijuana 40

Cannabis Law Report

AUGUST 6, 2021

In this article, we’ll tell you what some of the top health benefits of CBD products are: Mental Health Disorders. A lot of people are not comfortable with taking pharmaceutical medication. CBD can be a great way to treat your pain without taking pharmaceutical medication. Inflammation is often the cause of these disorders.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

Cannabis Law Report

JULY 23, 2021

such as GW Pharmaceuticals’ Epidyolex product) 7. This is a point on which we suggest that legal advice is obtained in relation to each specific situation.

Medicine 105

Medicine Legislation Cannabis Business 105

Cannabis Law Report

AUGUST 5, 2021

Additionally, the technology backed by the patent will be essential for transforming variable psychedelic raw materials into pharmaceutical-grade standardized extracts. FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing. For more information, visit filament.health.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

Cannabis Cheri

DECEMBER 17, 2021

They might even elaborate a bit and say that you are not likely to find a single patient in a hospital bed anywhere just because they use marijuana, but that’s another article. This article is all about the effects of smoking marijuana and lung health. This post was originally published in 2017.

Marijuana 130

Marijuana Media Patients DEA 130

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” .

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

Cannabis Law Report

JUNE 20, 2021

According to the World Health Organization, the toxicity of THC is “very low” compared to most other recreational and pharmaceutical drugs. How toxic is THC?

THC 81

THC CBD Food Safety 81

Project CBD

FEBRUARY 1, 2023

Cannabinoids for Inflammatory Skin Diseases To start, consider a recent article in the journal Pharmaceuticals 4 that examines previous research into cannabis-based medicines for inflammatory skin diseases such as acne, 5 eczema, dermatitis, and psoriasis. Pharmaceuticals (Basel, Switzerland) vol. 38,3 (2005): 177-88.

Conditions 130

Conditions THC CBD Cannabinoids 130

Cannabis Law Report

SEPTEMBER 21, 2022

Additionally, the Polish Pharmaceutical Chamber estimates that the potential number of medical cannabis users could reach 300,000, while this figure remains negligible and amounts to just 1,500 in 2021. Read full article. In Poland, over 2.3 million people consumed cannabis both legally and illegally as of 2021.

Pharmaceutical 52

Pharmaceutical THC Cannabis CBD 52

Cannabis Law Report

AUGUST 27, 2021

The policy for deregulation was announced on the 23rd when representatives of growers in Tochigi, Mie, Gifu Prefecture and Hokkaido visited Mr. Mitsuaki Kamada, Director of the Pharmaceutical and Living Hygiene Bureau of the Ministry of Health, Labor and Welfare.

Pharmaceutical 98

Pharmaceutical Cultivation Data Policy 98

Canna Law Blog

JULY 15, 2019

Currently, seven of Canada’s top ten cannabis patent holders are major multi-national pharmaceutical companies, according to a joint research project by Washington D.C.-based A Special Order may usually be obtained without difficulty upon payment of a government fee of CAD $500 (at the time of writing this article, that’s USD $382.31).

Pharmaceutical 105

Pharmaceutical Research and Development Data Cannabinoids 105

The Cannigma

JANUARY 24, 2021

This article was first published on Analytical Cannabis. Blaskovich and his colleagues at Botanix Pharmaceuticals Limited, which funded most of the research, believe the study’s results are promising enough to move the CBD formulations onto clinical trials. It appears here with permission. A future drug?

CBD 141

CBD Clinical Trials Treatment Pharmaceutical 141

The Cannigma

MAY 23, 2021

This article was first published on Analytical Cannabis. The research was partly funded by Rhodes Pharmaceuticals, a wholly owned subsidiary of Purdue Pharma. It is republished here with permission. Cannabis is used by countless patients all over the world for pain relief.

Marijuana 131

Marijuana THC Cannabinoids Patients 131

Cannabis Law Report

NOVEMBER 22, 2019

399/15 intends to amend article 2 of Law No. In tandem with Anvisa’s proposed regulations, there is a Bill on the floor of the House of Representatives to allow the commercialization of Cannabis sativa-based medicines.

Sativa 59

Sativa Medicine Legalization Epilepsy 59

Cannabis Law Report

NOVEMBER 17, 2021

Says Cannabis Health News article. The National Pharmaceutical Regulatory agency (NPRA) approved Sativex in 2014 for patients experiencing muscle spasms and spasticity from multiple sclerosis. Malaysia is set to allow the import and use of medical cannabis if the products comply with government regulations. Sativex in Malaysia.

Research and Development 111

Research and Development Patients Treatment Pharmaceutical 111